Key result
Preoperative LVEF >0.35 was associated with higher 4-year survival compared to LVEF ≤0.35 (73% vs 38%, p<0.05) following mitral valve replacement for coronary artery disease.
Why the study?
Does preoperative left ventricular ejection fraction impact survival in patients undergoing mitral valve replacement for ischemic mitral regurgitation?
Cohort (n=46)
Does preoperative left ventricular ejection fraction impact survival in patients undergoing mitral valve replacement for ischemic mitral regurgitation?
Answers are grounded in this paper and cite their sources.
Preoperative left ventricular ejection fraction >0.35 is associated with significantly better 4-year survival following mitral valve replacement for ischemic mitral regurgitation.
Forty-six patients who underwent mitral valve replacement for mitral regurgitation due to coronary artery disease during 1970-1975 were identified. Forty patients underwent aortocoronary bypass procedures at the same operation. The survival rate at the fourth postoperative year was 73% in the 22 patients in whom the preoperative left ventricular ejection fraction exceeded 0.35, 38% in the 16 patients in whom the preoperative left ventricular ejection fraction was 35% or less, and 25% in the eight patients in whom aneurysmectomy was performed at the time of mitral valve replacement (p less than 0.05 for the former group compared to the latter two groups). Heart failure, present preoperatively in 41 patients, was improved in most of the long-term survivors. Neither the angiographic extent of coronary artery disease nor whether mitral valve replacement was performed in the acute (within 2 months in 13 patients) or chronic phase of myocardial infarction were distinctly correlated with survival.
No takes yet. Share an insight, caveat, or question.
Radford et al. (1979) conducted a cohort in Mitral regurgitation due to coronary artery disease (n=46). Preoperative left ventricular ejection fraction > 0.35 vs. Preoperative left ventricular ejection fraction ≤ 0.35 was evaluated on Survival rate at the fourth postoperative year (p=<0.05). Preoperative LVEF >0.35 was associated with higher 4-year survival compared to LVEF ≤0.35 (73% vs 38%, p<0.05) following mitral valve replacement for coronary artery disease.
Synapse has enriched 10 related papers. Consider them for comparative context: